long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in...
TRANSCRIPT
![Page 1: Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome by Andrea Sarkozy, Tim Boussy, Georgios](https://reader036.vdocument.in/reader036/viewer/2022062423/5697c0281a28abf838cd6fd9/html5/thumbnails/1.jpg)
Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome
by Andrea Sarkozy, Tim Boussy, Georgios Kourgiannides, Gian-Battista Chierchia, Sergio Richter, Tom De Potter, Peter Geelen, Francis Wellens, Marieke Dingena
Spreeuwenberg, and Pedro Brugada
EHJVolume 28(3):334-344
February 5, 2007
© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: [email protected]
![Page 2: Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome by Andrea Sarkozy, Tim Boussy, Georgios](https://reader036.vdocument.in/reader036/viewer/2022062423/5697c0281a28abf838cd6fd9/html5/thumbnails/2.jpg)
Examples of positive ajmaline test results.
Andrea Sarkozy et al. Eur Heart J 2007;28:334-344
© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: [email protected]
![Page 3: Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome by Andrea Sarkozy, Tim Boussy, Georgios](https://reader036.vdocument.in/reader036/viewer/2022062423/5697c0281a28abf838cd6fd9/html5/thumbnails/3.jpg)
(A) Kaplan–Meier appropriate shock-free survival analysis in the study population.
Andrea Sarkozy et al. Eur Heart J 2007;28:334-344
© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: [email protected]
![Page 4: Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome by Andrea Sarkozy, Tim Boussy, Georgios](https://reader036.vdocument.in/reader036/viewer/2022062423/5697c0281a28abf838cd6fd9/html5/thumbnails/4.jpg)
Example of initiation of monomorphic VT in a 64-year-old male patient taking quinidine therapy.
Andrea Sarkozy et al. Eur Heart J 2007;28:334-344
© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: [email protected]
![Page 5: Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome by Andrea Sarkozy, Tim Boussy, Georgios](https://reader036.vdocument.in/reader036/viewer/2022062423/5697c0281a28abf838cd6fd9/html5/thumbnails/5.jpg)
(A) Kaplan–Meier IS-free survival analysis in the study population.
Andrea Sarkozy et al. Eur Heart J 2007;28:334-344
© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: [email protected]
![Page 6: Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome by Andrea Sarkozy, Tim Boussy, Georgios](https://reader036.vdocument.in/reader036/viewer/2022062423/5697c0281a28abf838cd6fd9/html5/thumbnails/6.jpg)
Examples of IS for atrial arrhythmias with fast ventricular rates.
Andrea Sarkozy et al. Eur Heart J 2007;28:334-344
© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: [email protected]